Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000903423-15-000112
Filing Date
2015-02-13
Accepted
2015-02-12 18:41:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 glaxoregulus-13ga2_0212.htm SC 13G/A 29976
  Complete submission text file 0000903423-15-000112.txt   31501
Mailing Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS
Business Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS 011442080475000
GLAXOSMITHKLINE PLC (Filed by) CIK: 0001131399 (see all company filings)

EIN.: 000000000
Type: SC 13G/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Subject) CIK: 0001505512 (see all company filings)

EIN.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87002 | Film No.: 15608265
SIC: 2834 Pharmaceutical Preparations